{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:57:57Z","timestamp":1769083077316,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalsofvascularsurgery.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.avsg.2014.02.018","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T19:32:27Z","timestamp":1392838347000},"page":"1513-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of Cilostazol on Arterial Wound Healing: A Retrospective Analysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Karen A.","family":"Resnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian L.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2014.02.018_bib1","first-page":"1154","article-title":"Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency","volume":"35","author":"Kawamura","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib2","first-page":"1124","article-title":"The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man","volume":"35","author":"Akiyama","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib3","first-page":"1163","article-title":"General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: effect on the peripheral organs","volume":"35","author":"Shintani","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib4","first-page":"1198","article-title":"Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans","volume":"35","author":"Yasuda","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5551\/jat.3392","article-title":"Anti-inflammatory role of cilostazol in vascular smooth muscle cells in\u00a0vitro and in\u00a0vivo","volume":"17","author":"Aoki","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.avsg.2014.02.018_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0003319710371619","article-title":"Cilostazol increases skin perfusion pressure in severely ischemic limbs","volume":"62","author":"Miyashita","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.avsg.2014.02.018_bib7","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvs.2008.11.098","article-title":"The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease","volume":"49","author":"O'Donnell","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1358836X0100600305","article-title":"Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication","volume":"6","author":"Mohler","year":"2001","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2014.02.018_bib9","first-page":"540","article-title":"Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy","volume":"42","author":"Okuda","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib10","first-page":"1201","article-title":"Hemodynamic effects of the antithrombotic drug cilostazol in chronic arterial occlusion in the extremities","volume":"35","author":"Kamiya","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib11","first-page":"1203","article-title":"Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion","volume":"35","author":"Ohashi","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib12","first-page":"1531","article-title":"Effects of cilostazol on platelet function","volume":"39","author":"Uehara","year":"1989","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.07.010","article-title":"Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials","volume":"18","author":"Uchiyama","year":"2009","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.avsg.2014.02.018_bib14","first-page":"1186","article-title":"Clinical effects of oral cilostazol on suppression of platelet function in patients with cerebrovascular disease","volume":"35","author":"Yasunaga","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.avsg.2014.02.018_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12264-009-6192-2","article-title":"Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke","volume":"25","author":"Guo","year":"2009","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.avsg.2014.02.018_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jvs.2009.08.040","article-title":"Cilostazol reduces restenosis after carotid artery stenting","volume":"51","author":"Takigawa","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib17","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.104.530097","article-title":"Coronary stent restenosis in patients treated with cilostazol","volume":"112","author":"Douglas","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2014.02.018_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0741-5214(98)70357-X","article-title":"Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease","volume":"27","author":"Money","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.avsg.2014.02.018_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2014.02.018_bib21","first-page":"52","article-title":"Pharmacotherapy as adjunctive treatment for serious foot wounds in the patient with diabetes: a case study","volume":"49","author":"Miller","year":"2003","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/j.avsg.2014.02.018_bib22","first-page":"77","article-title":"Adjunctive therapy for ischemic wounds using cilostazol","volume":"15","author":"Carson","year":"2003","journal-title":"Wounds"},{"key":"10.1016\/j.avsg.2014.02.018_bib23","first-page":"55","article-title":"Successful pharmacologic treatment of lower extremity ulcerations in 5 patients with chronic critical limb ischemia","volume":"15","author":"Dean","year":"2002","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.avsg.2014.02.018_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/j.1067-1927.2004.0abstractx.x","article-title":"The use of cilostazol in the treatment of Raynauld's disease with digital ischemia and tissue loss","volume":"12","author":"Serena","year":"2004","journal-title":"Wound Repair and Regeneration"},{"key":"10.1016\/j.avsg.2014.02.018_bib25","first-page":"537","article-title":"Clinical usefulness of cilostazol in the treatment of skin ulcer of patients with collagen disease","volume":"14","author":"Kondo","year":"1994","journal-title":"Drug Eval"},{"key":"10.1016\/j.avsg.2014.02.018_bib26","first-page":"60","article-title":"Clinical analysis of Pletal for intractable skin ulcer based on vascular damage and cutis symptom. Shin'yaku to Risho","volume":"42","author":"Arakawa","year":"1993","journal-title":"J New Remedies Clin"},{"key":"10.1016\/j.avsg.2014.02.018_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.12968\/jowc.2004.13.2.26580","article-title":"Foot ulceration due to arterial insufficiency: role of cilostazol","volume":"13","author":"Zolli","year":"2004","journal-title":"J Wound Care"},{"key":"10.1016\/j.avsg.2014.02.018_bib28","first-page":"310","article-title":"Conservative regimen for chronic critical limb ischemia","volume":"87","author":"Stapanavatr","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.avsg.2014.02.018_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0038-1634210","article-title":"Direct text entry in electronic progress notes. An evaluation of input errors","volume":"42","author":"Weir","year":"2003","journal-title":"Methods Inf Med"},{"key":"10.1016\/j.avsg.2014.02.018_bib30","first-page":"369","article-title":"Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease","volume":"100","author":"Cronenwett","year":"1986","journal-title":"Surgery"},{"key":"10.1016\/j.avsg.2014.02.018_bib31","first-page":"160","article-title":"Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial","volume":"1","author":"Schuler","year":"1984","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jvs.2005.11.041","article-title":"Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia","volume":"43","author":"Brass","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/ejvs.2000.1175","article-title":"Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia","volume":"20","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0950-821X(05)80337-8","article-title":"Treatment of limb threatened ischaemia with intravenous iloprost: a randomized double-blind placebo controlled study","volume":"5","author":"Bliss","year":"1991","journal-title":"Eur J vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jvs.2007.11.043","article-title":"Improving limb salvation in critical ischemia with intermittent pneumatic compression: a controlled study with 18 month follow up","volume":"48","author":"Kavros","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib36","first-page":"76","article-title":"Adjuvant pharmacologic therapy in the management of ischemic foot ulcers: results of the HEALing of Ischemic Foot Ulcers with Cilostazol Trial (HEAL-IT)","author":"Sumpio","year":"2006","journal-title":"Int J Angiol"},{"key":"10.1016\/j.avsg.2014.02.018_bib37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0741-5214(95)70018-8","article-title":"A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems","volume":"22","author":"Ballard","year":"1995","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF02001886","article-title":"TcPO2 as an accurate predictor of therapy in limb salvage","volume":"10","author":"Bunt","year":"1996","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2014.02.018_bib39","first-page":"301","article-title":"Application of transcutaneous oximetry in vascular surgery","volume":"7","author":"Szala","year":"1988","journal-title":"Int Angiol"},{"key":"10.1016\/j.avsg.2014.02.018_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jvs.2006.03.026","article-title":"Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization","volume":"44","author":"Marston","year":"2006","journal-title":"J Vasc Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509614001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509614001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:47:03Z","timestamp":1565207223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509614001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0890509614001137"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2014.02.018","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Cilostazol on Arterial Wound Healing: A Retrospective Analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2014.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}